GlassScriptPhysician profile
Jeffrey M Straub
NPI 1295116010
$1,301.20
in general payments reported to CMS, 2019-2025
19 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $382 · 2023: $156 · 2024: $150 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $396.72 | 2022-2025 | Inspire |
| C2dx, INC | $169.20 | 2022 | |
| Smith+Nephew, INC. | $126.20 | 2021-2025 | Halo, Tula |
| Baudax Bio INC. | $124.89 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $115.08 | 2023-2025 | Dupixent |
| Genzyme Corporation | $74.33 | 2023-2025 | |
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Philips North America LLC | $35.36 | 2025 | Encore |
| Olympus America INC. | $29.38 | 2022 | |
| Ascendis Pharma Endocrinology INC | $29.19 | 2025 | Yorvipath |
| Intersect Ent, INC. | $27.57 | 2021 | |
| Ambu INC. | $24.90 | 2024 | |
| Phathom Pharmaceuticals, INC. | $20.41 | 2025 | Voquezna |
| Jazz Pharmaceuticals INC. | $16.80 | 2025 | |
| Integra Lifesciences Corporation | $16.38 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.43 | 2023 | |
| Kaleo, INC. | $14.58 | 2022 | |
| Convatec INC. | $14.41 | 2024 | |
| Genentech USA, INC. | $13.35 | 2023 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Straub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.